Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK
Crossref DOI link: https://doi.org/10.1186/s12962-015-0048-6
Published Online: 2015-12-12
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Punekar, Yogesh Suresh
Roberts, Graeme
Ismaila, Afisi
O’Leary, Martin
Funding for this research was provided by:
GlaxoSmithKline foundation (GB)